COVID-19 & Other Infections.
How ImmuView® can help

When a patient is first presented with suspected pneumonia, it is difficult to differentiate between COVID-19 pneumonia and bacterial pneumonia, based on clinical features alone1.

At the same time, bacterial co-infections are relatively infrequent in hospitalized patients with COVID-192.
It is therefore important to ensure correct treatment of both COVID-19 patients and patients presented with pneumonia symptoms.

Antibiotic use & COVID-19

As COVID-19 is caused by a virus, antibiotics are ineffective unless there is a bacterial infection1.

Bacteria-based diseases like Legionella and pneumonia present symptoms that can be similar to those from COVID-191, but the treatments are different.  A simultaneous use of COVID-19 tests, as well as other test, should be considered to ensure correct treatment.

A rapid option is Immuview® S. pneumoniae & Legionella Urinary Antigen Test as it allows professionals to quickly determine an appropriate course of action.

Learn more about immuview®

Advantages of using COVID-19 and Immuview® P&L tests simultaneously

  • Rapid & easy to use
  • Two results in one test
  • More informed decision-making

The Rapid, Low-Cost
Diagnostic tool

The UK’s National Institute for Health and Care Excellence (NICE) has created a guideline, presenting a range of tests to be considered, including a Legionella and pneumococcal antigen test, for more informed decision making about antibiotic use1.

The following tests in the graph are to be considered.

As Easy as 123

Get results fast in 3 simple steps

Introduce sample

Add the sample to the test tube

Add buffer

Add the running buffer
and whirl gently

Insert test

Insert the test and wait
just 15 minutes

Book a meeting today

You probably have a lot of questions about ImmuView®. We have the answers. And we’d love to show you how easily you can take your testing to a new level of convenience, speed and accuracy. So book a demo today.

    More about ImmuView®?